Baxter Internationalvs.Boston Scientific
BAX vs BSX · both in Medtech & devices, part of the Medicine, pharma & life science value chain: Medical equipment and devices — from surgery and cardiology to robotics.
Boston Scientific is about 5.7× larger than Baxter International by market cap; year to date, Baxter International leads (+18.4% vs −53.0%).
Side by side
| BAX | BSX | |
|---|---|---|
| Market cap | $11.7B | $66.5B |
| Price | $22.62 | $44.77 |
| Today | +0.7% | −0.5% |
| Return YTD | +18.4% | −53.0% |
| Return 1Y | −23.8% | −56.9% |
| P/E | — | 18.7 |
| P/S | 1.0 | 3.2 |
| P/B | 1.9 | 2.6 |
Data as of 2026-07-11 · updates daily after U.S. close
The two companies
Baxter InternationalBAX
Hospital products across infusion, renal care and surgery.
Full BAX profile →Boston ScientificBSX
American medtech company with strong growth in cardiology — including electrophysiology (Farapulse) and structural heart treatment.
Full BSX profile →More comparisons in Medtech & devices
See where BAX and BSX sit in the full Medicine, pharma & life science map — every segment from suppliers to end markets.Open the Life science value chain →